Detalhe da pesquisa
1.
Prolonged viral pneumonia and high mortality in COVID-19 patients on anti-CD20 monoclonal antibody therapy.
Eur J Clin Microbiol Infect Dis
; 43(4): 723-734, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38358552
2.
Association of serum neurofilament light with microglial activation in multiple sclerosis.
J Neurol Neurosurg Psychiatry
; 94(9): 698-706, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37130728
3.
Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis.
Eur J Neurol
; 30(8): 2365-2375, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154404
4.
Whole Brain Adiabatic T1rho and Relaxation Along a Fictitious Field Imaging in Healthy Volunteers and Patients With Multiple Sclerosis: Initial Findings.
J Magn Reson Imaging
; 54(3): 866-879, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675564
5.
Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
Brain
; 143(11): 3318-3330, 2020 12 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33006604
6.
Effects of age, BMI and sex on the glial cell marker TSPO - a multicentre [11C]PBR28 HRRT PET study.
Eur J Nucl Med Mol Imaging
; 46(11): 2329-2338, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31363804
7.
PET-measurable innate immune cell activation reduction in chronic active lesions in PPMS brain after rituximab treatment: a case report.
J Neurol
; 270(4): 2329-2332, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36576574
8.
TSPO-Detectable Chronic Active Lesions Predict Disease Progression in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(5)2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349108
9.
Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 9(4)2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35581004
10.
Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET.
Brain Commun
; 4(1): fcab301, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34993478
11.
Association between microglial activation and serum kynurenine pathway metabolites in multiple sclerosis patients.
Mult Scler Relat Disord
; 59: 103667, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35151985
12.
Fingolimod treatment reverses signs of diffuse white matter damage in multiple sclerosis: A pilot study.
Mult Scler Relat Disord
; 48: 102690, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33352357
13.
Increased serum glial fibrillary acidic protein associates with microstructural white matter damage in multiple sclerosis: GFAP and DTI.
Mult Scler Relat Disord
; 50: 102810, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33556656
14.
High serum neurofilament associates with diffuse white matter damage in MS.
Neurol Neuroimmunol Neuroinflamm
; 8(1)2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33293460
15.
Rituximab in the treatment of multiple sclerosis in the Hospital District of Southwest Finland.
Mult Scler Relat Disord
; 40: 101980, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32066031
16.
Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
Neurol Neuroimmunol Neuroinflamm
; 7(3)2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32123046
17.
Natalizumab treatment reduces microglial activation in the white matter of the MS brain.
Neurol Neuroimmunol Neuroinflamm
; 6(4): e574, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31355310
18.
Microglial activation, white matter tract damage, and disability in MS.
Neurol Neuroimmunol Neuroinflamm
; 5(3): e443, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520366
19.
Evaluation of the Effect of Fingolimod Treatment on Microglial Activation Using Serial PET Imaging in Multiple Sclerosis.
J Nucl Med
; 58(10): 1646-1651, 2017 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28336784